SERP1 Is a Novel Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients via Anti-Apoptosis and Regulating SRPRB/NF-κB Axis
International Journal of Oncology - Greece
doi 10.3892/ijo.2017.4111
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2017
Authors
Publisher
Spandidos Publications